āagman

Not investment advice. Data and computed figures, for information only.

Biocon Ltd

NSE: BIOCONF&O
₹349.20
−₹2.80 (−0.80%)
NSE · 16 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹56,942 Cr
CMP
₹349.20
52-wk High / Low
₹447 / 338
P/E
78.3
P/B
1.7
Book Value
₹210.0
Div Yield
0.14%
ROCE
4.0%
ROE
1.4%
Face Value
₹5
D/E
0.45

Price−0.1% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 15 quarters of filings. Not reported by the company.
As of 16 Oct 2026
How we compute these
Piotroski F-Score
5
/ 9
5 of 9 F-score tests passed
Graham Number
₹106
√(22.5 × EPS × book value per share)
ROIC
2.5%
vs 11.2% sector median
Cash flow to profit
5.40
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+10
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
1.2%
ROE × earnings retention ratio
ROE stability
2.8
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom −0.23FII +0.62DII −0.68
Latest quarter vs the previous one
Cash-accrual divergence
−2.7%
of assets
Low = accruals track cash flow
Strengths
Watch-outs
−Latest ROCE of 4% trails the sector median of 17%
−Borrowings are up 522.8% since FY2016 (2478 to 15434)
−Price trades below its 200-day moving average (0.9x)
−Promoter holding fell by 16.0pp over the last year

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales3,4233,4623,9543,9173,4333,5903,8214,4173,9424,2964,1734,5174,336
Expenses2,7412,7453,0513,0042,8122,9053,0703,3393,1763,4603,3403,4963,489
Operating Profit6817179039136206857521,0787668358341,020847
OPM %19.9%20.7%22.8%23.3%18.1%19.1%19.7%24.4%19.4%19.4%20.0%22.6%19.5%
Other Income94134587401,1665853576281−176−2841
Interest233248267227236226223212277272210232213
Depreciation358389414407405420425436455473515513547
Profit before tax1842148083191,1469815648797171−68248128
Net Profit149173753223862278145989133−52199137
EPS (₹)0.841.055.501.135.49−0.130.212.870.230.631.080.780.87

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales3,0903,3473,8914,1235,5146,3007,1438,18411,17414,75615,26216,92717,321
Expenses2,3942,9572,9123,2944,1214,6965,5626,3918,76211,54012,00813,45613,785
Operating Profit6963909808291,3941,6041,5811,7932,4123,2163,2543,4713,536
OPM %22.5%11.7%25.2%20.1%25.3%25.5%22.1%21.9%21.6%21.8%21.3%20.5%20.4%
Other Income15863917322834019926072188531,217−76−82
Interest929266271655868419974897990927
Depreciation2212492773854485527158141,1131,5691,6871,9572,049
Profit before tax6247518506101,2151,1861,0689838971,5251,887448479
Net Profit5286096884531,0038718467726431,2981,429369416
EPS (₹)4.144.595.103.107.546.246.175.403.858.528.442.383.36

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital100100100300300600600600600600600810—
Reserves3,1713,9344,7384,8815,7986,1067,0277,83217,26719,18321,04433,221—
Borrowings1,1172,4782,3022,2642,4222,7154,4815,14718,01916,27718,36215,434—
Other Liabilities1,9881,9472,2542,5453,6724,9936,3826,76315,85619,69318,53413,943—
Total Liabilities6,3758,4589,3949,99012,19214,41418,49020,34251,74255,75358,54063,409—
Fixed Assets1,6301,7483,6263,7004,4715,9716,3646,56929,46830,64431,96336,486—
CWIP1,6772,2408391,3031,8992,1962,8004,1107,3177,9938,5086,987—
Investments2309021,2536751,0129661,9521,5882,0691,0001,1271,779—
Other Assets2,8393,5693,6764,3124,8115,2817,3748,07412,88816,11716,94118,157—
Total Assets6,3758,4589,3949,99012,19214,41418,49020,34251,74255,75358,54063,409—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity5612113716406621,1551,2831,1601,1771,8522,9544,0611,994
Cash from Investing Activity−904−491−1,138−510−684−703−1,505−3,651−1,662−14,260−1,002−203−1,883
Cash from Financing Activity4261861,068−178−240−2423882,56424213,049−2,333−1,854−924
Net Cash Flow83−94300−47−26121016572−243641−3802,004−812

Ratios

As of 31 Mar 2026
13 periods
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %15.012.09.012.08.013.013.010.09.06.06.06.04.0
ROE %————————————1.4
EPS (₹)3.454.144.595.103.107.546.246.175.403.858.528.442.38
Book Value (₹)————————————210.0
Face Value (₹)————————————5
P/E————————————78.3
Div Yield %————————————0.14
NPM %15.016.315.316.910.417.113.411.49.45.78.38.72.2
OPM %24.023.012.025.020.025.025.022.022.022.022.021.021.0
D/E0.290.340.610.480.440.400.400.590.611.010.820.850.45
P/B————————————1.7

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+18.0%
5 years+19.0%
3 years+15.0%
TTM+10.0%
Compounded profit growth
10 years+1.0%
5 years−12.0%
3 years−15.0%
TTM+100.0%
Stock price CAGR
10 years+8.0%
5 years−1.0%
3 years+10.0%
Last year−1.0%
Return on equity
10 years6.0%
5 years4.0%
3 years3.0%
Last year1.0%

Shareholding pattern

As of 31 Mar 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters60.68%60.68%60.67%60.67%60.67%60.67%60.64%60.64%60.64%60.64%44.91%44.68%
FIIs17.71%17.71%16.99%17.90%14.98%16.30%15.62%10.20%5.63%5.67%7.52%8.14%
DIIs3.72%3.72%3.93%4.38%7.32%7.14%8.36%11.89%13.69%15.73%24.01%23.33%
Government0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.05%0.05%
Public16.12%16.12%16.91%15.62%15.80%14.96%14.76%16.70%19.74%17.77%23.40%23.75%
No. of shareholders1,00,7611,00,7611,34,4881,53,7932,06,9963,11,3493,47,9114,11,0864,70,2614,24,2973,86,5933,92,833
Change since Jun 2023 (pp)
Promoters −16.00FIIs −9.57DIIs +19.61Public +7.63

Documents

As of 11 Oct 2026
Announcements
Disclosure Pursuant To Regulation 30 Of The SEBI Listing RegulationsGrant Of Employee Stock Options Under Biocon Unity Long Term Incentive Plan 2026 Read With The Notified Plans ThereunderClosure of Trading WindowCompany SecretaryAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026RecordingJun 2026TranscriptJun 2026PPTMay 2026PPTFeb 2026TranscriptFeb 2026PPTFeb 2026PPT

Corporate actions

As of 3 Jul 2026
3 Jul 2026DIVIDENDDividend - Re 0.50 Per Share—
4 Jul 2025DIVIDENDDividend - Rs 0.50 Per Share—
5 Jul 2024DIVIDENDDividend - Re 0.50 Per Share—
7 Jul 2023DIVIDENDDividend - Rs 1.50 Per Share—
30 Jun 2022DIVIDENDDividend - Rs 0.50 Per Share—
18 Jul 2019DIVIDEND Dividend - Rs 0.50 Per Share—
12 Jun 2019BONUS Bonus 1:1—
19 Jul 2018DIVIDEND Dividend- Re 1 Per Share—
20 Jul 2017DIVIDEND Annual General Meeting/Dividend - Re 1/- Per Share—
15 Jun 2017BONUS Bonus 2:1—
17 Mar 2016DIVIDEND Interim Dividend - Rs 5/- Per Share (Purpose Revised)—
9 Apr 2015DIVIDENDInterim Dividend Rs 5/- Per Share—
10 Jul 2014DIVIDENDAnnual General Meeting / Final Dividend - Rs 5/- Per Share—
11 Jul 2013DIVIDENDAnnual General Meeting/Final Dividend Rs 5/- Per Share + Special Dividend Rs 2.5/- Per Share—
5 Jul 2012DIVIDENDAnnual General Meeting / Dividend Rs 5 Per Share—
7 Jul 2011DIVIDENDAnnual General Meeting/Dividend Rs 3 Per Share—
5 May 2011DIVIDENDInterim Dividend-Rs.1.50 Per Share (Purpose Revised)—
8 Jul 2010DIVIDENDAnnual General Meeting And Dividend Rs.3.50 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman